US 12419873
Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases
granted A61KA61K31/437A61K31/438
Quick answer
US patent 12419873 (Use of JAK inhibitors in preparation of drugs for treating JAK kinase-related diseases) held by ZHUHAI UNITED LABORATORIES CO., LTD. expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ZHUHAI UNITED LABORATORIES CO., LTD.
- Grant date
- Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/437, A61K31/438, A61P, A61P1/04